Expression of Epidermal Growth Factor Receptor in Breast Carcinoma

Overview

Journal J Clin Pathol

Specialty Pathology

Date 1990 May 1

PMID 2370306

Citations 31

Authors

S Lewis

A Locker

J H Todd

J A Bell

R Nicholson

C W Elston

R W Blamey

I O Ellis

Affiliations

Soon will be listed here.

Abstract

A series of 90 patients with primary operable breast cancer and with up to 36 months of follow up were investigated for expression of epidermal growth factor receptor (EGFR) in their tumours by immunocytochemical staining with the monoclonal antibody EGFR 1. Tumour samples were snap frozen in liquid nitrogen immediately after resection and subsequently stained using a standard indirect immunocytochemical method. Tumour staining was assessed by two observers and scored on a four point scale (0-3). Thirteen (14%) tumours showed positive immunoreactivity. A strong correlation between distinct EGFR expression and short disease free interval was observed. Significant correlations were also shown with oestrogen and progesterone receptor expression and tumour nuclear size. No significant association was found with tumour size, lymph node stage, and histological grade. The association with disease free interval remained significant in multivariate analysis.

Citing Articles

Fatty acid synthase affects expression of ErbB receptors in epithelial to mesenchymal transition of breast cancer cells and invasive ductal carcinoma.

Chen T, Zhou L, Li H, Tian Y, Li J, Dong L Oncol Lett. 2017; 14(5):5934-5946.

PMID: 29113229 PMC: 5661422. DOI: 10.3892/ol.2017.6954.

The combinatorial approach of laser-captured microdissection and reverse transcription quantitative polymerase chain reaction accurately determines HER2 status in breast cancer.

Hofmann E, Seeboeck R, Jacobi N, Obrist P, Huter S, Klein C Biomark Res. 2016; 4:8.

PMID: 27057311 PMC: 4823853. DOI: 10.1186/s40364-016-0062-7.

Clinicopathological Characteristics and Survival Outcomes of Invasive Cribriform Carcinoma of Breast: A SEER Population-Based Study.

Liu X, Jiang Y, Liu Y, Zuo W, Shao Z Medicine (Baltimore). 2015; 94(31):e1309.

PMID: 26252312 PMC: 4616584. DOI: 10.1097/MD.0000000000001309.

Radish (Raphanus sativus L. leaf) ethanol extract inhibits protein and mRNA expression of ErbB(2) and ErbB(3) in MDA-MB-231 human breast cancer cells.

Kim W, Kim J, Jeong D, Chun Y, Kim S, Cho K Nutr Res Pract. 2011; 5(4):288-93.

PMID: 21994522 PMC: 3180678. DOI: 10.4162/nrp.2011.5.4.288.

Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas.

Magkou C, Nakopoulou L, Zoubouli C, Karali K, Theohari I, Bakarakos P Breast Cancer Res. 2008; 10(3):R49.

PMID: 18522728 PMC: 2481499. DOI: 10.1186/bcr2103.

References

Kurachi H, Okamoto S, Oka T . Evidence for the involvement of the submandibular gland epidermal growth factor in mouse mammary tumorigenesis. Proc Natl Acad Sci U S A. 1985; 82(17):5940-3. PMC: 390669. DOI: 10.1073/pnas.82.17.5940. View

Cohen S . Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem. 1962; 237:1555-62. View

Taylor-Papadimitriou J, Shearer M, Stoker M . Growth requirements of human mammary epithelial cells in culture. Int J Cancer. 1977; 20(6):903-8. DOI: 10.1002/ijc.2910200613. View

Osborene C, Hamilton B, Nover M . Receptor binding and processing of epidermal growth factor by human breast cancer cells. J Clin Endocrinol Metab. 1982; 55(1):86-93. DOI: 10.1210/jcem-55-1-86. View

Dickson R, Lippman M . Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocr Rev. 1987; 8(1):29-43. DOI: 10.1210/edrv-8-1-29. View

Todd J, Dowle C, Williams M, Elston C, Ellis I, Hinton C . Confirmation of a prognostic index in primary breast cancer. Br J Cancer. 1987; 56(4):489-92. PMC: 2001834. DOI: 10.1038/bjc.1987.230. View

Blamey R, Davies C, Elston C, Johnson J, Haybittle J, Maynard P . Prognostic factors in breast cancer -- the formation of a prognostic index. Clin Oncol. 1979; 5(3):227-36. View

Sainsbury J, Malcolm A, Appleton D, Farndon J, Harris A . Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer. J Clin Pathol. 1985; 38(11):1225-8. PMC: 499417. DOI: 10.1136/jcp.38.11.1225. View

Pekonen F, Partanen S, Makinen T, Rutanen E . Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer. Cancer Res. 1988; 48(5):1343-7. View

10.

Sainsbury J, Farndon J, Sherbet G, Harris A . Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer. Lancet. 1985; 1(8425):364-6. DOI: 10.1016/s0140-6736(85)91385-6. View

11.

Osborne C, Hamilton B, Titus G, Livingston R . Epidermal growth factor stimulation of human breast cancer cells in culture. Cancer Res. 1980; 40(7):2361-6. View

12.

Barnes D . Breast cancer and a proto-oncogene. BMJ. 1989; 299(6707):1061-2. PMC: 1837980. DOI: 10.1136/bmj.299.6707.1061. View

13.

Maynard P, Blamey R, Elston C, Haybittle J, Griffiths K . Estrogen receptor assay in primary breast cancer and early recurrence of the disease. Cancer Res. 1978; 38(11 Pt 2):4292-5. View

14.

Sainsbury J, Farndon J, Needham G, Malcolm A, Harris A . Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet. 1987; 1(8547):1398-402. DOI: 10.1016/s0140-6736(87)90593-9. View

15.

Cohen S, Carpenter G . Human epidermal growth factor: isolation and chemical and biological properties. Proc Natl Acad Sci U S A. 1975; 72(4):1317-21. PMC: 432524. DOI: 10.1073/pnas.72.4.1317. View

16.

Gusterson B, Cowley G, Smith J, Ozanne B . Cellular localisation of human epidermal growth factor receptor. Cell Biol Int Rep. 1984; 8(8):649-58. DOI: 10.1016/0309-1651(84)90045-6. View